Press release
Multiple Myeloma Market Growth, Trends, and Forecast 2025 | Top key players - Amgen Inc., Sanofi, Novartis AG.
The Global Multiple Myeloma Market reached US$ 22.3 billion in 2024 and is expected to reach US$ 34.58 billion by 2032, growing at a CAGR of 5.6% during the forecast period 2025-2032.Multiple Myeloma Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.
The Multiple Myeloma Market involves the development and commercialization of treatments for multiple myeloma, a cancer that affects plasma cells in the bone marrow. This market includes therapies like chemotherapy, immunotherapy, stem cell transplants, and targeted therapies aimed at managing symptoms, improving patient outcomes, and extending survival. Innovations continue to drive growth, especially in personalized and combination treatments.
Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/multiple-myeloma-market?sz
Market Opportunities and Growth Drivers:
Rising number of product approvals
The multiple myeloma treatment market is seeing significant growth, thanks to the increasing number of product approvals that are expanding treatment options and offering new hope for patients. As research and development efforts intensify, more innovative therapies are meeting the safety and efficacy standards required by regulatory bodies.
For example, in April 2024, Johnson & Johnson received approval from the U.S. Food and Drug Administration (FDA) for CARVYKTI (ciltacabtagene autoleucel; cilta-cel), a cutting-edge treatment for adult patients with relapsed or refractory multiple myeloma. This approval is particularly significant for patients who have already undergone at least one prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent, and are no longer responding to lenalidomide. CARVYKTI stands out as the first and only B-cell maturation antigen (BCMA)-targeted therapy authorized for use in multiple myeloma patients as early as their first relapse.
These ongoing approvals of innovative therapies like CARVYKTI are a key driver of growth in the multiple myeloma treatment market, improving patient outcomes and providing new solutions for this challenging disease.
Multiple Myeloma Market Recent Development:
In April 2024, Bristol Myers Squibb (BMS) and 2seventy bio, Inc. celebrated a significant milestone with the FDA's approval of ABECMA (idecabtagene vicleucel) for treating adult patients with relapsed or refractory multiple myeloma. This treatment option is for patients who have already undergone two or more prior therapies, including an immunomodulatory agent (IMiD), a proteasome inhibitor (PI), and an anti-CD38 monoclonal antibody.
In March 2024, Kite, a Gilead Company, and Arcellx, Inc. shared exciting updates on their collaboration regarding anito-cel, an innovative BCMA CAR T-cell therapy for multiple myeloma. Anito-cel is the first of its kind to incorporate Arcellx's novel and compact D-Domain binder, marking an important step in the ongoing search for effective treatments in multiple myeloma.
List of the Key Players in the Multiple Myeloma Market:
Amgen Inc., Sanofi, Novartis AG, Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, ONO PHARMACEUTICAL CO., LTD., Pfizer Inc., Karyopharm and Amneal Pharmaceuticals LLC. among others.
Research Process:
Both primary and secondary data sources have been used in the global Multiple Myeloma Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/multiple-myeloma-market
Segment Covered in the Multiple Myeloma Market:
By Type: Smoldering (Indolent) Multiple Myeloma, Active (Symptomatic) Multiple Myeloma.
By Treatment: Chemotherapy, Immunotherapy, Radiation, Stem Cell Transplant, Targeted Therapy.
By End-User: Hospitals, Cancer Centers, Others.
Regional Analysis for Multiple Myeloma Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
People Also Ask:
Most Frequently Asked Questions in the Multiple Myeloma Market Research Industry:
➠ What are the global figures for sales, production, consumption, imports, and exports in the Multiple Myeloma market?
➠ Who are the top manufacturers in the global Multiple Myeloma industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?
➠ What key opportunities are available for vendors in the Multiple Myeloma market, and what challenges are they likely to encounter?
➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?
➠ What are the major drivers and barriers influencing the growth trajectory of the Multiple Myeloma market?
➠ What are the primary sales, marketing, and distribution strategies used across the global Multiple Myeloma industry landscape?
Browse More Reports: https://www.datamintelligence.com/research-report/multiple-myeloma-market
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiple Myeloma Market Growth, Trends, and Forecast 2025 | Top key players - Amgen Inc., Sanofi, Novartis AG. here
News-ID: 4009115 • Views: …
More Releases from DataM Intelligence 4Market Research

Soaring Ahead: How the Aircraft Powertrain Control Market Is Powering Next-Gen A …
As per the DataM Intelligence, The Global Aircraft Powertrain Control Market reached US$ 6.5 billion in 2022 and is expected to reach US$ 11.0 billion by 2030, growing with a CAGR of 6.8% during the forecast period 2024-2031. Rising demand for fuel-efficient engines, increased aircraft production, and advancements in next-generation powertrain technologies are driving market growth.
Unlock exclusive insights with our detailed sample report (Corporate Email ID to get priority access)…

Soaring Sparks: How the Aircraft Ignition Systems Market is Powering Next-Gen Av …
As per the DataM Intelligence, The Global Aircraft Ignition System Market is expected to grow at a Significant CAGR during the forecast period 2024-2031. Rising demand for new aircraft deliveries, increasing air passenger traffic, and growing adoption of advanced electronic ignition systems to enhance engine performance and fuel efficiency are driving the market growth.
Unlock exclusive insights with our detailed sample report (Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/aircraft-ignition-systems-market?sz
The…

Sky-High Demand: How Aircraft Aerodynamic Seals Market Is Shaping the Future of …
As per the DataM Intelligence, The Global Aircraft Aerodynamic Seals Market reached US$ 1.0 billion in 2023 and is expected to reach US$ 1.8 billion by 2031, growing with a CAGR of 7.4% during the forecast period 2024-2031. Rising demand for fuel-efficient aircraft, increasing production of commercial and military planes, and advancements in lightweight, durable sealing technologies are driving market growth.
Unlock exclusive insights with our detailed sample report (Corporate Email…

Next-Gen Aerospace Landing Gear Market Set to Soar: Innovations Fuel Global Grow …
As per the DataM Intelligence, The Aerospace Landing Gear Market is expected to grow at a CAGR 8.2% in the forecast period of (2024-2031). Rising global aircraft production, increasing air passenger traffic, and demand for lightweight, fuel-efficient landing gear systems are driving market growth.
Unlock exclusive insights with our detailed sample report (Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/aerospace-landing-gear-market?sz
The Aerospace Landing Gear Market encompasses the design, production, and supply…
More Releases for Multiple
Mango AI's Multiple Face Swap Video Tool Changes Multiple Faces Instantly
In today's digital world, creating eye-catching and unique content is essential for standing out. The ability to swap multiple faces in a single video opens up creative possibilities, whether for personalized content, comedy or parody videos, or engaging social media posts. Mango AI, developed by Mango Animate, is excited to announce the launch of its advanced multiple face swap video (https://mangoanimate.com/ai/multiple-face-swap-video) tool, which is designed to simplify the creation of…
Multiple Sclerosis Drugs Market
Global Multiple Sclerosis Drugs Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market.
Get a Sample Copy of the Report at - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100386
Multiple Sclerosis (MS) is an immune-mediated disease affecting the central nervous system. It is characterized by demyelination, inflammation, degenerative changes such as progressive brain and spinal cord atrophy and neuroaxonal…
Massive Multiple Input Multiple Output (MIMO) Market May Set New Growth Story
A Latest intelligence report published by MR Forecast with title "Global Massive Multiple Input Multiple Output (MIMO) Market Outlook to 2032. A detailed study accumulated to offer Latest insights about acute features of the Massive Multiple Input Multiple Output (MIMO) market. This report provides a detailed overview of key factors in the Global Massive Multiple Input Multiple Output (MIMO) Market and factors such as driver, restraint, past and current trends,…
Multiple Sclerosis Drugs Market - Progressing Towards a Cure: Advancing Multiple …
Newark, New Castle, USA: The "Multiple Sclerosis Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiple Sclerosis Drugs Market: https://www.growthplusreports.com/report/multiple-sclerosis-drugs-market/7983
This latest report researches the industry structure,…
Multiple Sclerosis Drugs Market - Empowering Resilience, Embracing Possibilities …
Newark, New Castle, USA - new report, titled Multiple Sclerosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Multiple Sclerosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Multiple Sclerosis Drugs market. The report offers an overview of…
Massive MIMO (Multiple-input multiple-output) Market 2022-2028 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Massive MIMO (Multiple-input multiple-output) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Massive MIMO (Multiple-input multiple-output) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Massive MIMO (Multiple-input multiple-output)…